“Patterns Of Hedgehog Inhibitor (HHI) Treatment Interruptions and Reinitiations Among Patients with Basal Cell Carcinoma (BCC) in Real-World Clinical Practice”, J of Skin, vol. 4, no. 6, p. s123, Oct. 2020, doi: 10.25251/skin.4.supp.123.